Health Technology · Pharmaceuticals: Major · NSE: SIGACHI · data 2026-10-09
Sigachi Industries Limited
Health check: Average (5.3/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹28.52
Market cap
₹1,092 cr
P/E
43
P/B
—
ROE
-14.6%
ROCE
6.1%
Debt / equity
0.31
Dividend yield
0.35%
1-year return
-26.7%
52-week high
₹40.8
52-week low
₹16.65
Operating margin
6.1%
Growth
| Revenue (last 12 months) | ₹471 cr |
| Net profit (last 12 months) | ₹25 cr |
| Sales growth, 3 years (yearly) | 16.5% |
| Profit growth, 3 years (yearly) | — |
Similar companies
Remus Pharmaceuticals Ltd. (REMUS) · Lincoln Pharmaceuticals Ltd (LINCOLN) · Bajaj Healthcare Ltd (BAJAJHCARE) · Themis Medicare Limited (THEMISMED) · Bafna Pharmaceuticals Limited (BAFNAPH)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open SIGACHI in NSE Scanner →